Tobramycin: an overview.
D000293:Adolescent; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003864:Depression, Chemical; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D007223:Infant; D007700:Kinetics; D008297:Male; D014176:Protein Biosynthesis; D011549:Pseudomonas / Q000187:drug effects; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014031:Tobramycin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D014031:Tobramycin